Please assess the completion status of the following clinical trial:

Trial Title: Clinical Safety and Efficacy of CT ASPHINA 509 Lenses

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~Patient informed of the consequences and constraints of the protocol and who has given his/her written informed consent;~* Patients of any gender~* Assured follow-up examinations~* Biometry measurement preferably compatible with the IOLMaster evaluation;~* IOL implanted into the capsular bag with IOL model CT ASPHINA 409MP (UVE material) in one eye with at least 12 months follow up at the time of the postop visit~* Patients who had uncomplicated (no peroperative complication) agedrelated cataract surgery in a healthy eye (beside clinically significant cataract)~Exclusion Criteria:~* • BCVA not available preoperatively or better than 0.3 logMAR pre-op~  * Patients unable to meet the limitations of the protocol or likely of noncooperation during the trial~ * Patients whose freedom is impaired by administrative or legal order~ * Concurrent participation in another drug or device investigation

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 509 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).